IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,637 | -99.9% | 267,997 | +92.2% | 0.02% | +42.9% |
| Q3 2022 | $1,336,000 | -62.3% | 139,467 | -34.5% | 0.01% | -44.0% |
| Q1 2022 | $3,546,000 | +183.7% | 212,974 | +225.1% | 0.02% | +257.1% |
| Q4 2021 | $1,250,000 | -29.3% | 65,514 | -8.6% | 0.01% | -36.4% |
| Q3 2021 | $1,768,000 | -52.9% | 71,704 | -11.4% | 0.01% | -85.5% |
| Q4 2020 | $3,756,000 | +22.1% | 80,965 | -27.8% | 0.08% | -17.4% |
| Q2 2020 | $3,077,000 | – | 112,098 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,674,299 | $65,948,000 | 5.28% |
| Ghost Tree Capital, LLC | 700,000 | $17,262,000 | 5.05% |
| Perceptive Advisors | 11,489,772 | $283,337,000 | 4.12% |
| Prosight Management, LP | 274,761 | $6,776,000 | 3.73% |
| Fairmount Funds Management LLC | 389,588 | $9,607,000 | 3.49% |
| Avoro Capital Advisors LLC | 8,500,000 | $209,610,000 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 374,495 | $9,235,000 | 3.26% |
| Ally Bridge Group (NY) LLC | 406,986 | $10,036,000 | 2.95% |
| Parametrica Management Ltd | 146,362 | $3,609,000 | 2.70% |
| COMMODORE CAPITAL LP | 362,869 | $8,948,000 | 2.36% |